
Global Clinical Laboratory Market: by-Country Market Analysis (U.S., China, Japan, Germany, France, Spain, Italy, Brazil, EMEA and others)
Description
This report represents a solid research and benchmarking tool for market planners in diagnostics and laboratory test services for clinical purposes. Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East, Africa; Asia Pacific; Latin America; Total)
- Northern America Market Value by Country, 2016 (Canada, United States, Rest of Northern America)
- U.S. Clinical Laboratory Market Analysis, 2010-2021
- U.S. Clinical Laboratory Market Analysis by Laboratory Type, 2010-2021 (Hospital-based, Physician-office, Independent, Total)
- Clinical Laboratory Market Share by Laboratory Type, 2021 (Independent, Hospital-based, Physician-office)
- U.S. Clinical Laboratory Market Analysis: Testing Service Revenues by Type, 2016 (Routine Clinical Chemistry, Toxicology / Drug abuse, Tissue Pathology, Other Specialty)
- Europe/Middle East and Africa Market Value by Country, 2016 (Germany, France, Italy, Spain, United Kingdom, Switzerland, Rest of EMEA, Total)
- Asia Pacific Market Value by Country, 2016 (China, Japan, India, South Korea, Australia, Rest of Asia Pacific, Total)
- Latin America Market Value by Country, 2016 (Brazil, Mexico, Rest of Latin America, Total)
Table of Contents
200 Pages
- CHAPTER ONE: EXECUTIVE SUMMARY
- INDUSTRY AT A GLANCE
- SCOPE AND METHODOLOGY
- GLOBAL MARKET OVERVIEW
- Table 1-1: Global Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer’s level)
- Figure 1-1: Global Clinical Laboratory Market Analysis: 2010-2021
- MARKET CONCLUSIONS
- KEY ISSUES AND TRENDS AFFECTING THE MARKET
- LEADING MARKET PARTICIPANTS
- CHAPTER TWO: INDUSTRY OVERVIEW
- CLINICAL LABORATORY DESCRIPTION
- TESTING AND SERVICES
- Routine Testing
- Table 2-1: Laboratory Reference Parameters for Complete Blood Count (CBC)
- Table 2-2: High Cholesterol Risk Categories (Desirable levels, Borderline high, High risk)
- Table 2-3: Raised or At-Risk Total Cholesterol (> = 190 mg/dL), Age Standardized Estimates, 2008 data (Iceland, Germany, Denmark,
- United Kingdom, Ireland, Italy, France, Netherlands, Switzerland, United Arab Emirates, Singapore, Japan, Poland, Thailand, Australia,
- United States, Israel, Canada, Mexico, Russian Federation, Argentina, Brazil, Philippines, Republic of Korea, Turkey, Saudi Arabia,
- Venezuela, China, India)
- Table 2-4: Number of Reported HIV Testing and Counseling Services by Country, 2014 (India, Ethiopia, Uganda, Kenya, Nigeria,
- Mozambique, South Africa, Rwanda, United Republic of Tanzania, Zambia, Mexico, Kazakhstan, Malawi, Viet Nam, Côte d'Ivoire,
- Democratic Republic of the Congo, Zimbabwe, Malaysia, Thailand, Haiti, Peru, Belarus, Indonesia, Burundi, Cuba)
- Table 2-5: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2015 (Afghanistan, Argentina,
- Australia, Belgium, Brazil, Canada, China, Democratic People's Republic of Korea, Denmark, France, Germany, India, Indonesia, Iran
- [Islamic Republic of], Iraq, Israel, Italy, Japan, Mexico, Netherlands, New Zealand, Philippines, Poland, Republic of Korea, Russian
- Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom
- of Great Britain and Northern Ireland, United States of America, Venezuela [Bolivarian Republic of], Viet Nam)
- Table 2-6: HCG Levels in Pregnant Women by Days Past Ovulation
- Table 2-7: Substance Detection Periods by Test Method (Alcohol, Cocaine, Morphine, Phenobarbital, Methadone, PCP, LSD, Heroin,
- Methamphetamine; Urine, Blood, Hair)
- Table 2-8: Screening and Brief Interventions for Substance Abuse by Select Country, 2008 Data (Afghanistan, Australia, Austria,
- Belgium, Canada, China, Denmark, France, Germany, Greece, Hungary, Iceland, India, Indonesia, Iran [Islamic Republic of], Iraq,
- Ireland, Israel, Italy, Japan, Mexico, Netherlands, New Zealand, Norway, Pakistan, Philippines, Poland, Republic of Korea, Russian
- Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, Venezuela [Bolivarian Republic of])
- Table 2-9: Normal Reference Levels in a Medical Urinalysis
- Specialty Testing
- GLOBAL CLINICAL LABORATORY STRUCTURE
- Global Hospital/Acute Care Data
- Table 2-10: Hospital Density per 100,000 Population by Country, 2013 (Afghanistan, Brazil, Canada, China, France, Finland, Germany,
- Iceland, Indonesia, Iraq, Israel, Italy, Japan, Korea [Republic of], Malaysia, Mexico, Netherlands, Pakistan, Philippines, Poland, Saudi
- Arabia, Singapore, South Africa, Thailand, Turkey, United Kingdom, United States)
- Figure 2-1: Hospitals per 100,000 Population by Country, 2013 (Afghanistan, Brazil, Canada, China, France, Finland, Germany, Iceland,
- Indonesia, Iraq, Israel, Italy, Japan, Korea [Republic of], Malaysia, Mexico, Netherlands, Pakistan, Philippines, Poland, Saudi Arabia,
- Singapore, South Africa, Thailand, Turkey, United Kingdom, United States)
- Global Access to Physicians
- Table 2-11: Medical Doctors per 1,000 Population by Country, 2013 (Afghanistan, Argentina, Australia, Brazil, Canada, China, France,
- Germany, India, Ireland, Israel, Italy, Japan, Mexico, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey, United
- Kingdom, United States, Vietnam)
- Figure 2-2: Medical Doctors per 1,000 Population by Country, 2013 (Afghanistan, Argentina, Australia, Brazil, Canada, China, France,
- Germany, India, Ireland, Israel, Italy, Japan, Mexico, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey, United
- Kingdom, United States, Vietnam)
- CLIA Laboratory Registration, Laboratories by Type
- Figure 2-6: U.S. CLIA Clinical Laboratory Registration by Primary Laboratory Type: 1/2017 (Physician Office, Skilled Nursing / Nursing
- Facility, Home Health Agency, Hospital, Pharmacy, Community Clinic, ESRD Clinic, Independent, Others)
- Table 2-13: CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined), January 2017 (Ambulance, Ambulatory
- Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Bank, Community Clinic, Comprehensive Outpatient Rehab, End Stage
- Renal Disease Dialysis, Federally Qualified Health Center, Health Fair, Health Maintenance Organization, Home Health Agency, Hospice,
- Hospital, Independent, Industrial, Insurance, Intermediate Care Facility for Mentally Retarded, Mobile Laboratory, Pharmacy, Physician
- Office, Other Practitioner, Prison, Public Health Laboratory, Rural Health Clinic, School/Student Health Service, Skilled Nursing/Nursing
- Facility, Tissue Bank/Repository, Other, Total)
- Figure 2-7: Change in CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined) June 2013, July 2015 and
- January 2017 (Ambulance, Ambulatory Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Banks, Community Clinic,
- Comprehensive Outpatient Rehab, End Stage Renal Disease Dialysis, Federally Qualified Health Center, Health Fair, Health Maintenance
- Organization, Home Health Agency, Hospice, Hospital, Independent, Industrial, Insurance, Intermediate Care - Mentally Retarded, Mobile
- Laboratory, Pharmacy, Physician Office, Other Practitioner, Prison, Public Health Laboratory, Rural Health Clinic, School/Student Health
- Service, Skilled Nursing, Tissue Bank/Repositories, Other)
- Independent Clinical Laboratories
- Table 2-14: Leading U.S. Independent Laboratory Groups, as of January 2017
- Figure 2-8: Leading U.S. Independent Laboratory Groups, Distribution of Centers, as of January 2017
- Figure 2-9: Growth in U.S. Independent Laboratory Facilities, mid-2011 through January 2017
- Laboratory Health Workers by Country, 2010-2014 Average (United States, China, Brazil, Korea, Mexico, Canada)
- CHAPTER THREE: ISSUES AND TRENDS IN THE CLINICAL LABORATORY INDUSTRY
- ISSUES AND TRENDS OVERVIEW
- DEMOGRAPHICS
- Global Demographics
- Table 3-1: The Global Population, 1980-2050
- Figure 3-1: The Global Population, 1980-2050 (in millions)
- Regional Population Overview
- Table 3-2: World Population by Major Geographic Region, 2010 - 2050 (Asia Pacific, Europe, Northern America, Latin America, Rest of
- World, World)
- Figure 3-2: World Population by Major Geographic Region, 2010–2050 (Asia Pacific, Europe, Northern America, Latin America, Rest of
- World)
- Aging Populations
- Table 3-3: Global Population Trends Age 65+, 2000-2050
- Figure 3-3: Global Population Trends Age 65+, 2000-2050 (Millions)
- INCIDENCE OF CHRONIC DISEASES AND CONDITIONS
- Figure 3-4: Global Causes of Death, 2014 and 2015
- SURGICAL PROCEDURE VOLUMES
- Table 3-4: Global Surgical Procedure Volume Forecast by Region, 2015-2030*
- (procedures in thousands) (Northern America, Europe, Asia Pacific, Latin America, Rest of World, Total) .. 69
- REGULATORY OVERVIEW
- Certificate of Waiver
- Table 3-5: Selected CLIA Waived Laboratory Tests
- Certificate of Provider-Performed Microscopy Procedures (PPMP)
- Table 3-6: Provider-Performed Microscopy Procedures
- Certificate of Compliance and Certificate of Accreditation
- Figure 3-5: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), January 2017
- Table 3-7: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), January 2017
- States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
- Table 3-8: CLIA Exempt States, Number of Laboratories, January 2017 (New York, Washington)
- PAYERS AND REIMBURSEMENT
- Laboratory Service Payer Types
- Table 3-9: U.S. Clinical Laboratory Clients and Payers by Type (%) (Medicare and Medicaid, Private Patient, Commercial Insurance,
- Managed Care)
- Figure 3-6: Clinical Laboratory Clients and Payers by Type (Medicare/Medicaid, Private, Commercial, Managed Care)
- Trends in Medicare Reimbursement
- Table 3-10: Medicare Reimbursement Trends, 2009 vs. 2013 vs. 2015 vs. 2016
- Health Care Reform
- Protecting Access to Medicare Act (PAMA) of 2014
- Bundled Insurance Payments for ESRD Patients
- Table 3-11: Laboratory Tests Subject to ESRD Consolidated Billing (CY 2017)
- Table 3-12: Comparison between New Bundled and Composite Medicare Reimbursement Program (1983-2010 and 2011+)
- Commercial Insurance Providers
- NEW DEVELOPMENTS IN INFORMATION TECHNOLOGY
- CHAPTER FOUR: LEADING MARKET PARTICIPANTS
- SUMMARY
- Figure 4-1: Leading Market Participants, Global Service Revenues, 2014, 2015 and 2016 ($millions)
- U.S. COMPETITIVE ANALYSIS
- Table 4-1: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2016
- Figure 4-2: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2016
- Figure 4-3: Estimated U.S. Laboratory Service Revenues for Leading Clinical Laboratory Providers, 2010 vs. 2016
- ALERE, INC.
- Company Overview
- Table 4-2: Alere Corporate Details
- Performance Review
- Figure 4-4: Alere Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- BIO-REFERENCE LABORATORIES - OPKO
- Company Overview
- Table 4-3: Bio-Reference Laboratories Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- DAVITA HEALTHCARE PARTNERS, INC.
- Company Overview
- Table 4-4: DaVita Healthcare Corporate Details
- Performance Review
- Figure 4-5: DaVita Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- GENOMIC HEALTH, INC.
- Company Overview
- Table 4-5: Genomic Health Corporate Details
- Performance Review
- Figure 4-6: Genomic Health Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- LABORATORY CORPORATION OF AMERICA
- Company Overview
- Table 4-6: Laboratory Corporation of America Corporate Details
- Performance Review
- Figure 4-7: Laboratory Corporation of America Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- MYRIAD GENETICS, INC.
- Company Overview
- Table 4-7: Myriad Genetics Corporate Details
- Performance Review
- Figure 4-8: Myriad Genetics Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- NEOGENOMICS, INC.
- Company Overview
- Table 4-8: NeoGenomics, Inc. Corporate Details
- Performance Review
- Figure 4-9: NeoGenomics Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- QUEST DIAGNOSTICS, INC.
- Company Overview
- Table 4-9: Quest Diagnostics Corporate Details
- Performance Review
- Figure 4-10: Quest Diagnostics Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- SIEMENS HEALTHINEERS
- Company Overview
- Table 4-10: Siemens Healthineers Corporate Details
- Performance Review
- Figure 4-11: Siemens' Healthineers Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- SONIC HEALTHCARE LIMITED
- Company Overview
- Table 4-11: Sonic Healthcare Corporate Details
- Performance Review
- Figure 4-12: Sonic Healthcare Revenue Summary, 2010-2016 ($millions)
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- SPECTRA LABORATORIES: A FRESENIUS COMPANY
- Company Overview
- Table 4-12: Spectra Laboratories Corporate Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- SYNLAB INTERNATIONAL GMBH
- Company Overview
- Table 4-13: SYNLAB International Corporate Details
- Performance Review
- Table 4-14: SYNLAB International Business Combination Details
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- CHAPTER FIVE: MARKET TRENDS AND SUMMARY
- GLOBAL MARKET OVERVIEW
- Table 5-1: Global Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer’s level)
- Figure 5-1: Global Clinical Laboratory Market Analysis: 2010-2021
- SERVICE MARKETS BY TEST SEGMENT
- Figure 5-2: Global Clinical Laboratory Revenue Share by General Test Segment, 2016 (%)
- Table 5-2: Global Clinical Laboratory Market Analysis by Test Segment (Routine vs. Specialty), 2010-2021 (in millions of dollars at the
- manufacturers’ level)
- Routine Testing
- Table 5-3: Most Common Performed Routine Tests by Order Request, 2016
- Figure 5-3: Global Clinical Laboratory Market Analysis: Routine Testing Market Trend, 2010-2021
- Specialty Testing
- Table 5-4: Most Common Performed Specialty Tests by Order Request, 2016
- Figure 5-4: Global Clinical Laboratory Market Analysis: Specialty Testing Market Trend, 2010-2021
- CHAPTER SIX: REGIONAL MARKETS AND TRENDS
- OVERVIEW
- Table 6-1: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East,
- Africa; Asia Pacific; Latin America; Total)
- Figure 6-1: Global Clinical Laboratory Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East, Africa; Asia
- Pacific; Latin America)
- NORTHERN AMERICAN MARKET OVERVIEW
- Table 6-2: Northern America Market Value by Country, 2016 (in millions of dollars at the manufacturers’ level) (Canada, United States,
- Rest of Northern America)
- U.S. Clinical Laboratory Market
- Table 6-3: U.S. Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer’s level)
- Figure 6-2: U.S. Clinical Laboratory Market Analysis: 2010-2021
- Market Analysis by Laboratory Type
- Table 6-4: U.S. Clinical Laboratory Market Analysis by Laboratory Type, 2010-2021 (in millions of dollars at the manufacturers’ level)
- (Hospital-based, Physician-office, Independent, Total)
- EUROPE AND MIDDLE EAST MARKET OVERVIEW
- Table 6-5: Europe/Middle East and Africa Market Value by Country, 2016 (in millions of dollars at the manufacturers’ level) (Germany,
- France, Italy, Spain, United Kingdom, Switzerland, Rest of EMEA, Total)
- ASIA PACIFIC MARKET OVERVIEW
- Table 6-6: Asia Pacific Market Value by Country, 2016 (in millions of dollars at the manufacturers’ level) (China, Japan, India, South
- Korea, Australia, Rest of Asia Pacific, Total)
- LATIN AMERICA MARKET OVERVIEW
- Table 6-7: Latin America Market Value by Country, 2016 (in millions of dollars at the manufacturers’ level) (Brazil, Mexico, Rest of Latin
- America, Total)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.